A comprehensive brain imaging analysis has yielded striking data that challenges fundamental assumptions about long COVID’s neurological basis. Zero percent of studied patients demonstrated widespread brain inflammation markers—a critical finding given that neuroinflammation has been a leading theoretical explanation for persistent cognitive symptoms affecting this population.
Simultaneously, 85 percent of long COVID patients exhibited heightened activity in mood-related brain regions, with 72 percent showing significant changes in emotional processing networks. These statistics suggest a distinct neurobiological pattern characterized by functional rather than inflammatory changes. The data indicates that current anti-inflammatory treatment strategies may be less effective than therapies targeting emotional regulation and mood stabilization.
These quantitative findings represent a watershed moment in long COVID research, necessitating urgent reconsideration of therapeutic approaches.
Read the full article on GMJ Newsroom.
Was this article helpful?
